“…Even if litigation for negligent disclosure has not increased, many suggest that outcomes have become less predictable post-Montgomery. 5,32,36,42,47,60,64,77,100 This unpredictability is commonly attributed to uncertainty concerning how courts will assess material risks, 9,11,19,21,23,32,33,45,46,60,75,77,86,88,89,91,103 apply the subjective patient limb of the test, 9,18,22,23,31,36,41,42,48,60,81,86,90,92 allow the therapeutic exception, 5,6,22,25,31,33,34,37,[58][59]…”